A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801Paul A. Carpenter, Mukta Arora, Laura Johnston et al.|Haematologica|2018Cited by 55
Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials NetworkPaul A. Carpenter, Mukta Arora, Brent R. Logan et al.|Transplantation and Cellular Therapy|2016Cited by 5